Antihypertensive treatment and sexual dysfunction (Q38009740)

26 August 2017

Antihypertensive treatment and sexual dysfunction (English)

1 reference

26 August 2017

1 reference

Athanasios Manolis

1

1 reference

PubMed ID

22581395

26 August 2017

Michael Doumas

series ordinal

2

1 reference

26 August 2017

1 August 2012

1 reference

Current Hypertension Reports

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

285-292

1 reference

26 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-012-0276-5

26 August 2017

0 references

cites work

Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual dysfunction in essential hypertension: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

The effect of antihypertensive drugs on erectile function: a proposed management algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Female sexual dysfunction in essential hypertension: a common problem being uncovered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Hypertension and sexual dysfunction: time to act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual dysfunction is common in the morbidly obese male and improves after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Mediterranean diet improves sexual function in women with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Beneficial impact of exercise and obesity interventions on erectile function and its risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Evaluation of vitamin E in the treatment of erectile dysfunction in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Complementary and alternative medicine (CAM) for sexual dysfunction and erectile dysfunction in older men and women: an overview of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of antihypertensives on sexual function and quality of life: the TAIM Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effects of antihypertensive therapy on female sexual dysfunction: clinically meaningful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual activity in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sexual dysfunction in hypertensive patients treated with losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Cardiovascular risk, drugs and erectile function--a systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Erectile dysfunction after therapy with metoprolol: the Hawthorne effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE i

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Erectile dysfunction: from biochemical pharmacology to advances in medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effects of sildenafil citrate on human hemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Chapter 1: The management of erectile dysfunction: an AUA update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Cardiovascular effects of tadalafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Effect of treating erectile dysfunction on management of systolic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0276-5

Global burden of hypertension: analysis of worldwide data

21 January 2018

1 reference

12 December 2020

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

12 December 2020

Mediterranean diet improves erectile function in subjects with the metabolic syndrome

1 reference

12 December 2020

Morphological modifications in clitoris and vagina in spontaneously hypertensive rats

1 reference

12 December 2020

In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats

1 reference

12 December 2020

Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction

1 reference

12 December 2020

Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide.

1 reference

12 December 2020

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

1 reference

12 December 2020

Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

12 December 2020

Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group

1 reference

12 December 2020

Management of erectile dysfunction: do not forget hypertension

1 reference

12 December 2020

Factors Affecting the Increased Prevalence of Erectile Dysfunction in Greek Hypertensive Compared With Normotensive Subjects

1 reference

12 December 2020

Exercise training ameliorates the impairment of endothelial and nitrergic corpus cavernosum responses in diabetic rats

1 reference

12 December 2020

Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men.

1 reference

12 December 2020

10.1007/S11906-012-0276-5

Identifiers

DOI

1 reference

PubMed ID

22581395

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22581395